CURE spoke with Dr. Marina Kremyanskaya about the treatment landscape for patients with polycythemia vera.
The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...
Treatments with therapeutic phlebotomy and hydroxyurea are associated with improved overall survival and decreased risk of thrombosis in older patients with polycythemia vera, according to a recent ...
Of the 18 PV patients treated with PTG-300, the vast majority were able to eliminate therapeutic phlebotomies and maintain a target hematocrit level of less than 45 percent. Treatment with PTG-300 was ...
PARKVILLE, Mo.--(BUSINESS WIRE)--Bond Biosciences, Inc. “We are pleased to begin this first-in-human clinical trial of our lead non-absorbed oral therapy and thankful for the seasoned development team ...
CHARLESTON, S.C.--(BUSINESS WIRE)--The Blood Connection (TBC), your community blood center, is proud to serve the Charleston community through free therapeutic phlebotomy. This service is free for ...
NEWARK, Calif., Dec. 12, 2021 /PRNewswire/ -- Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") today presented updated data from two ongoing Phase 2 studies evaluating ...
Robin Meyer was adamant: “We have to do something for this patient.” Meyer, R.N.C. infusion nurse at AHN Cancer Institute at Saint Vincent, identified an urgent and important need for her patient, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback